These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 19886948

  • 1. The cost-effectiveness of macrogol 3350 compared to lactulose in the treatment of adults suffering from chronic constipation in the UK.
    Taylor RR, Guest JF.
    Aliment Pharmacol Ther; 2010 Jan 15; 31(2):302-12. PubMed ID: 19886948
    [Abstract] [Full Text] [Related]

  • 2. Cost-effectiveness of macrogol 4000 compared to lactulose in the treatment of chronic functional constipation in the UK.
    Guest JF, Clegg JP, Helter MT.
    Curr Med Res Opin; 2008 Jul 15; 24(7):1841-52. PubMed ID: 18558017
    [Abstract] [Full Text] [Related]

  • 3. Economic impact of low dose polyethylene glycol 3350 plus electrolytes compared with lactulose in the management of idiopathic constipation in the UK.
    Christie AH, Culbert P, Guest JF.
    Pharmacoeconomics; 2002 Jul 15; 20(1):49-60. PubMed ID: 11817992
    [Abstract] [Full Text] [Related]

  • 4. Pharmacoeconomic Impact of Low-Dose Macrogol 3350 plus Electrolytes Compared with Lactulose in the Management of Chronic Idiopathic Constipation among Ambulant Patients in Belgium.
    Guest JF, Varney SJ.
    Clin Drug Investig; 2004 Jul 15; 24(12):719-29. PubMed ID: 17523735
    [Abstract] [Full Text] [Related]

  • 5. Cost Effectiveness of Naloxegol for Opioid-Induced Constipation in the UK.
    Lawson R, Ryan J, King F, Goh JW, Tichy E, Marsh K.
    Pharmacoeconomics; 2017 Feb 15; 35(2):225-235. PubMed ID: 27663572
    [Abstract] [Full Text] [Related]

  • 6. Tolerance and Long-Term Efficacy of Polyethylene Glycol 4000 (Forlax®) Compared to Lactulose in Elderly Patients with Chronic Constipation.
    Chassagne P, Ducrotte P, Garnier P, Mathiex-Fortunet H.
    J Nutr Health Aging; 2017 Feb 15; 21(4):429-439. PubMed ID: 28346570
    [Abstract] [Full Text] [Related]

  • 7. Prucalopride for the treatment of women with chronic constipation in whom standard laxative regimens have failed to provide adequate relief.
    Pennant M, Orlando R, Barton P, Bayliss S, Routh K, Meads C.
    Health Technol Assess; 2011 May 15; 15 Suppl 1():43-50. PubMed ID: 21609652
    [Abstract] [Full Text] [Related]

  • 8. Cost-Effectiveness of Linaclotide Compared to Osmotic Laxatives in the Treatment of Irritable Bowel Syndrome with Constipation in China.
    Xiao D, Zhang Y, Chen W, Xuan J, Chen Y.
    Adv Ther; 2022 Jun 15; 39(6):2971-2983. PubMed ID: 35488140
    [Abstract] [Full Text] [Related]

  • 9. Polyethylene glycol compared to lactulose for constipation in pregnancy: A randomized controlled trial.
    Raj VI, Hassan A, Hanafiah N, Azhary JMK, Lim BK, Saaid R, Gan F, Tan PC.
    Int J Gynaecol Obstet; 2024 Aug 15; 166(2):828-836. PubMed ID: 38391250
    [Abstract] [Full Text] [Related]

  • 10. Stepped treatment of older adults on laxatives. The STOOL trial.
    Mihaylov S, Stark C, McColl E, Steen N, Vanoli A, Rubin G, Curless R, Barton R, Bond J.
    Health Technol Assess; 2008 May 15; 12(13):iii-iv, ix-139. PubMed ID: 18462572
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Management of constipation in residents with dementia: sorbitol effectiveness and cost.
    Volicer L, Lane P, Panke J, Lyman P.
    J Am Med Dir Assoc; 2004 May 15; 5(4):239-41. PubMed ID: 15228633
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Methylnaltrexone bromide for the treatment of opioid-induced constipation in patients with advanced illness--a cost-effectiveness analysis.
    Earnshaw SR, Klok RM, Iyer S, McDade C.
    Aliment Pharmacol Ther; 2010 Apr 15; 31(8):911-21. PubMed ID: 20096019
    [Abstract] [Full Text] [Related]

  • 18. Clinical and economic impact of using macrogol 3350 plus electrolytes in an outpatient setting compared to enemas and suppositories and manual evacuation to treat paediatric faecal impaction based on actual clinical practice in England and Wales.
    Guest JF, Candy DC, Clegg JP, Edwards D, Helter MT, Dale AK, Fell J, Cosgrove M, Debelle G.
    Curr Med Res Opin; 2007 Sep 15; 23(9):2213-25. PubMed ID: 17692152
    [Abstract] [Full Text] [Related]

  • 19. Long-term efficacy and cost-effectiveness of polyethylene glycol 3350 plus electrolytes in chronic constipation: a retrospective study in a disabled population.
    Migeon-Duballet I, Chabin M, Gautier A, Mistouflet T, Bonnet M, Aubert JM, Halphen M.
    Curr Med Res Opin; 2006 Jun 15; 22(6):1227-35. PubMed ID: 16846556
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.